Ovid Therapeutics Inc. Common Stock

OVIDNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
2.39 USD
↗ 0.02 (0.89%)🟢PRE MARKET (AS OF 07:31 PM EDT)
🟢Market: OPEN

Ovid Therapeutics Inc. Common Stock (OVID) trades at $2.39 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. OVID is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 6, 2026.

Open?$2.42
High?$2.46
Low?$2.28
Prev. Close?$2.37
Volume?1.5M
Avg. Volume?1.7M
VWAP?$2.37
Rel. Volume?0.92x
Bid / Ask
Bid?$1.94 × 100
Ask?$2.79 × 100
Spread?$0.85
Midpoint?$2.37
Valuation & Ratios
Market Cap?462.9M
Shares Out?195.3M
Float?158.0M
Float %?84.7%
P/E Ratio?N/A
P/B Ratio?2.21
EPS?-$0.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Rare Disease Therapeutics
Employees
23
Market Cap
462.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ovidrx.com
Listed
2017-05-05
Address
441 NINTH AVENUE, 14TH FLOOR
NEW YORK, NY 10001
Phone: 212-776-4381
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
50
Short Sent.?
28
Piotroski F-Score?1/9Weak
Altman Z-Score?10.21Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.38%High
Short Interest?21.2M
Days to Cover?17.3
Free Float158.0M
Avg Daily Volume1.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?12.39Strong
Quick Ratio?12.39Strong
Cash Ratio?1.13Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
70
2.21CHEAP▾
P/S?
Peers
100
S&P
3
292.39HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
285.24HIGH▾
Returns & Efficiency
ROE?
S&P
8
-16.4%WEAK▾
ROA?
S&P
3
-14.9%WEAK▾
Cash Flow & Enterprise
FCF?$-54773000
Enterprise Value?$451.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist